A African American may have access to groundbreaking treatment to prevent HIV infection. The treatment, known as Truvada for PrEP stops the spread of HIV in Australia, and researchers hope to test it globally in populations, according to a new study.
RATED: Do not Believe in the Hype: Seven HIV / AIDS Myths We Need to Stop
Truvada for PrEP or pre-exposure prophylaxis – a term that refers to the use of antiviral drugs to prevent HIV and AIDS – was celebrated as groundbreaking. New cases of HIV among gay and bisexual men fell by nearly a third to the lowest ever reported, according to a new study published by Australian researchers in the Lancet HIV medical journal. In the state of New South Wales, Australia, new HIV infections fell from 1
Australian researchers investigated and measured the results of Truvada, an antiviral prescription drug manufactured by Gilead Sciences Inc. in the form of a blue pill, for the first time with the study
"The rate of decline we encountered New HIV infections seen in gay and bisexual men is a world first, "said Study Director Andrew Grulich Head of HIV Epidemiology and Prevention at the Kirby Institute of the University of New South Wales. "These numbers are the lowest since the beginning of HIV surveillance in 1985."
HIV rates among newly-infected populations worldwide dropped to 1.8 million worldwide in 2017, a decline of more than 3 million a year most of the 1990s. African Americans saw a higher proportion of new HIV diagnoses compared to other races and ethnic groups. In 2016, African Americans accounted for 44 percent of HIV diagnoses, even though they accounted for only 12 percent of the US population, according to Centers for Disease Control and Prevention .
Truvada for PrEP, a fixed-dose mixture of tenofovir, disoproxil and emtricitabine, has been used for HIV prevention. About 180,000 people in the US took Truvada for PrEP at the end of June. Robin L. Washington Gilead's chief financial officer, said in July to Bloomberg . Areas of greatest benefit from PrEP saw some of the best reductions in HIV infection, said Gilead's Chief Executive Officer John F. Milligan
It is unclear how and when researchers continue to drive Truvada's use in the US But most likely, African Americans and other high-risk populations may be trying to take the treatment.
Real Life Uncle Ruckus! Minister Jesse Lee Peterson: "Black people have been so violent over the years
Frazzled White Woman calls police on black children:" It's like an uprising here!